Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

78 results about "Restriction fragment" patented technology

A restriction fragment is a DNA fragment resulting from the cutting of a DNA strand by a restriction enzyme (restriction endonucleases), a process called restriction. Each restriction enzyme is highly specific, recognising a particular short DNA sequence, or restriction site, and cutting both DNA strands at specific points within this site. Most restriction sites are palindromic, (the sequence of nucleotides is the same on both strands when read in the 5' to 3' direction of each strand), and are four to eight nucleotides long. Many cuts are made by one restriction enzyme because of the chance repetition of these sequences in a long DNA molecule, yielding a set of restriction fragments. A particular DNA molecule will always yield the same set of restriction fragments when exposed to the same restriction enzyme. Restriction fragments can be analyzed using techniques such as gel electrophoresis or used in recombinant DNA technology.

Molecule marking method for pig backfat thickness property

InactiveCN103497994ASolve the problems of high blindness and low selection accuracyShorten the generation intervalMicrobiological testing/measurementBOARAcyl coenzyme
The invention relates to a molecule marking method for pig backfat thickness property. The method comprises: extraction of pig genome DNA, design of a long-chain acyl-coenzyme Asynthetase 1 (ACSL1) gene seventh exon primer, amplification in vitro and genotype detection. For the first time, it is discovered that the polymorphism of the long-chain acyl-coenzyme Asynthetase 1 (ACSL1) gene seventeenth exon has significant correlation with the pig backfat thickness, and a method for detecting the restriction fragment polymorphism at mutation sites of the seventeenth exon is established. The molecule marking method is applicable to auxiliary selection on backfat thickness property during breeding of pigs, helps to realize early-stage breeding selection of boars, and even helps to accurately select breeding just when pigs are born, so that the generation interval is shortened, and the selection progress of the backfat thickness property is accelerated; and the method is simple in operation, condition requirements during a polymerase chain reaction are low, the length of amplified fragments is relatively short (292 bp), amplification is relatively easy, and the method helps to improve amplification efficiency and accuracy of genotype determining.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY MEDICINE ANHUI ACAD OF AGRI SCI

Method for identifying traditional Chinese medical material corn cervi pantotrichum based on PCR-RFLP

The invention discloses a method for identifying the traditional Chinese medical material corn cervi pantotrichum based on PCR-RFLP. A reagent kit used for identifying the traditional Chinese medical material corn cervi pantotrichum comprises a primer pair shown in (a) or (b) and restriction enzyme DdeI or isoschizomers of the restriction enzyme DdeI, wherein (a) is the primer pair composed of two lines of single-stranded DNA molecules shown in a sequence 1 and a sequence 2 in a sequence table, (b) is the primer pair which is composed of two lines of single-stranded DNA molecules shown in the sequence obtained by replacing and/or deleting and/or adding one or several nucleotides shown in the sequence 1 and the sequence 2 in the sequence table and is identical with the primer pair in (a) in function. According to the method, cytochrome b gene sequences of the traditional Chinese medical material corn cervi pantotrichum and counterfeit drug of the traditional Chinese medical material corn cervi pantotrichum are analyzed, different SNP loci of the traditional Chinese medical material corn cervi pantotrichum and the counterfeit drug of the traditional Chinese medical material corn cervi pantotrichum are obtained, identification primers and the restriction enzyme are designed, and the traditional Chinese medical material corn cervi pantotrichum and the counterfeit drug of the traditional Chinese medical material corn cervi pantotrichum are accurately identified through the restriction fragment length polymorohism polymerase chain reaction technology.
Owner:INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products